Table 2.
Sub-group analysis based on uveitis etiology
| PValue | ||||
|---|---|---|---|---|
| FUS | BU | IU | RDAU | |
| Postoperative visual acuity (at 12th month) | ||||
| PHU | 0.259 | 0.436 | 0.263 | 0.952 |
| FUS | < 0.001a | 0.123 | 0.785 | |
| BU | 0.015a | 0.852 | ||
| IU | 0.403 | |||
| Postoperative inflammation | ||||
| PHU | 0.738 | 0.293 | 0.738 | 0.492 |
| FUS | 0.025a | 0.380 | 0.297 | |
| BU | 0.128 | 0.308 | ||
| IU | 0.605 | |||
| Recurrence | ||||
| PHU | 0.738 | 0.293 | 0.738 | 0.492 |
| FUS | 0.016a | 0.380 | 0.297 | |
| BU | 0.128 | 0.308 | ||
| IU | 0.605 | |||
| Posterior Capsule Opacification | ||||
| PHU | 0.071 | 0.004a | 0.723 | 0.102 |
| FUS | 0.269 | 0.198 | 0.521 | |
| BU | 0.144 | 0.939 | ||
| IU | 0.141 | |||
| Cystoid Macular Edema | ||||
| PHU | 0.999 | 0.011a | 0.344 | 0.105 |
| FUS | < 0.001a | 0.222 | 0.699 | |
| BU | 0.015a | 0.383 | ||
| IU | 0.274 | |||
| Glaucoma | ||||
| PHU | 0.251 | 0.818 | 0.144 | 0.285 |
| FUS | 0.830 | 0.731 | 0.132 | |
| BU | 0.286 | 0.084 | ||
| IU | 0.184 | |||
PHU presumed herpetic uveitis, FUS Fuchs uveitis syndrome, BU Behçet uveitis, IU Idiopathic uveitis, RDAU rheumatic disease associated uveitis, a Statistically significant